News
Shares of Amgen Inc. AMGN rallied 1.13% to $290.33 Friday, on what proved to be an all-around great trading session for the ...
20h
Investor's Business Daily on MSNThe Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
Patent claims reciting compounds where at least one group of a compound genus is defined by its function are common. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results